Pramiconazole: Difference between revisions
Appearance
Content deleted Content added
removed Category:Para-Methoxyphenylpiperazines; added Category:Piperazines using HotCat |
auto mw |
||
Line 5: | Line 5: | ||
| Watchedfields = changed |
| Watchedfields = changed |
||
| verifiedrevid = 366890982 |
| verifiedrevid = 366890982 |
||
| IUPAC_name = 1-<nowiki/>{4-[4-(4- |
| IUPAC_name = 1-<nowiki/>{4-[4-(4-{[(2''R'',4''S'')-2-(2,4-difluorophenyl)-2-(1''H''-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one |
||
| image = Pramiconazole.png |
| image = Pramiconazole.png |
||
| width = |
| width = |
||
Line 50: | Line 50: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=35 | H=39 | F=2 | N=7 | O=4 |
| C=35 | H=39 | F=2 | N=7 | O=4 |
||
| molecular_weight = 659.725 |
|||
| SMILES = CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F |
| SMILES = CC(C)N1CCN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]5OC[C@](O5)(Cn6cncn6)c7ccc(cc7F)F |
||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
Latest revision as of 04:23, 25 March 2024
This article needs additional citations for verification. (January 2021) |
Clinical data | |
---|---|
Routes of administration | By mouth |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C35H39F2N7O4 |
Molar mass | 659.739 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pramiconazole is a triazole antifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.[1][2]
References
[edit]- ^ "Pramiconazole - AdisInsight".
- ^ Geria AN, Scheinfeld NS (September 2008). "Pramiconazole, a triazole compound for the treatment of fungal infections". IDrugs: The Investigational Drugs Journal. 11 (9): 661–70. PMID 18763217.